OSSIAM

Position in VTRS — Viatris Inc

CIK 1767471 PARIS, I0

Position in VTRS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$86,053

+$13,667 QoQ

Shares Held

5,419

+1.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#637

of 1,020 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OSSIAM holds $11,530,234 across 7 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INDV	Indivior Pharmaceuticals, Inc.	126,199	$5,177,944
2	TEVA	Teva Pharmaceutical Industries Ltd	74,058	$2,509,085
3	PBH	Prestige Consumer Healthcare Inc.	43,300	$2,046,791
4	ZTS	Zoetis Inc.	16,929	$1,216,517
5	UTHR	UNITED THERAPEUTICS Corp	494	$267,664
6	NBIX	Neurocrine Biosciences Inc	1,342	$226,180
7	VTRS	Viatris Inc This page	5,419	$86,053

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$86,053	5,419	+1.1%	Shares	Defined	2026-08-13
2026-03-31	$72,386	5,358	-28.1%	Shares	Defined	2026-05-14
2025-12-31	$92,715	7,447	-70.1%	Shares	Defined	2026-02-13
2025-06-30	$222,473	24,913	+315.6%	Shares	Defined	2025-08-13
2025-03-31	$52,207	5,994	-52.6%	Shares	Defined	2025-05-14
2024-06-30	$134,426	12,646	-48.5%	Shares	Defined	2024-08-13
2024-03-31	$292,924	24,533	-59.5%	Shares	Defined	2024-05-13
2023-03-31	$582,269	60,527	+221.1%	Shares	Defined	2023-05-12
2022-06-30	$197,328	18,847	-66.8%	Shares	Defined	2022-08-12
2022-03-31	$617,940	56,796	-62.0%	Shares	Defined	2022-05-13
2021-12-31	$2,019,690	149,275	+506.3%	Shares	Defined	2022-02-14
2021-09-30	$333,601	24,620	0.0%	Shares	Defined	2021-11-12
2021-06-30	$351,819	24,620	-57.7%	Shares	Defined	2021-08-13
2021-03-31	$813,417	58,226	-60.4%	Shares	Defined	2021-05-17
2020-12-31	$2,756,504	147,092	—	Shares	Defined	2021-02-12
No filing history on record for this holder in this stock.